Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two-sample Mendelian randomization study.

Psoriasis is a chronic, refractory inflammatory skin disease, with a high prevalence of psychiatric comorbidities, including depression, anxiety, and even suicidality, which may in turn initiate or exacerbate skin inflammation. However, the causal relationships between these comorbidities remain unclear. To investigate the cause-effect relationships between psoriasis and mental disorders including depression, anxiety, and suicidality, we conducted a bidirectional two-sample Mendelian randomization (MR) study utilizing summary statistics from the most comprehensive genome-wide association studies of psoriasis (n = 306 123), broad depression (n = 500 199), major depressive disorder (n = 173 005), anxiety (n = 17 310), and suicide attempts (n = 50 264). Using the random-effects inverse-variance weighted method as primary method, the forward MR analyses indicated that psoriasis was significantly associated with higher odds of broad depression (odds ratio [OR] 1.030, 95% confidence interval [CI] 1.010-1.051, P = 0.003) and suggestively associated with an increased risk of major depressive disorder (OR 1.054, 95% CI 1.002-1.109, P = 0.040), but not with the risk of anxiety (P = 0.160) or suicide attempts (P = 0.648). In reverse MR analyses, significant causal impact of broad depression (OR 1.363, 95% CI 1.103-1.684, P = 0.004) and major depressive disorder (OR 1.890, 95% CI 1.285-2.781, P = 0.001), but not anxiety (P = 0.787) and suicide attempts (P = 0.961) on psoriasis risk was observed. In addition, the results of primary analysis are consistent across sensitivity analyses, albeit the MR-Egger regression model produced wide CIs and negative results in several analyses. In conclusion, this MR study indicates a bidirectional causal relationship between psoriasis and depression that was previously unrecognized, which highlights the significance of screening for depression in psoriasis patients and initiating appropriate interventions. Further studies are required to elucidate the pathophysiology of the bidirectional causal relationship between these two conditions.

[1]  M. Husain,et al.  Associations between psoriasis and mental illness: an update for clinicians. , 2022, General hospital psychiatry.

[2]  J. Thyssen,et al.  Disease burden, symptoms and use of analgesics in patients with psoriasis with or without psoriatic arthritis: a cross-sectional study. , 2021, Journal of the American Academy of Dermatology.

[3]  Liyan Wang,et al.  Interleukin-6: Its role and mechanisms in rescuing depression-like behaviors in rat models of depression , 2019, Brain, Behavior, and Immunity.

[4]  L. Skov,et al.  Risk of first‐time and recurrent depression in patients with psoriasis: a population‐based cohort study , 2018, The British journal of dermatology.

[5]  R. Marioni,et al.  Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions , 2018, Nature Neuroscience.

[6]  T. Werge,et al.  Genetics of suicide attempts in individuals with and without mental disorders: a population-based genome-wide association study , 2018, Molecular Psychiatry.

[7]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[8]  F. Hartwig,et al.  Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique , 2016, International journal of epidemiology.

[9]  N. Wray,et al.  Meta-analysis of genome-wide association studies of anxiety disorders , 2015, Molecular Psychiatry.

[10]  C. Griffiths,et al.  Does psychosocial stress play a role in the exacerbation of psoriasis? , 2013, The British journal of dermatology.

[11]  S. González‐Parra,et al.  Psoriasis and Depression: The Role of Inflammation. , 2019, Actas dermo-sifiliograficas.